Soleus Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-78,000
| Closed | -$2.04M | – | 102 |
|
|
2022
Q4 | $2.04M | Hold |
78,000
| – | – | 0.29% | 59 |
|
|
2022
Q3 | $1.53M | Sell |
78,000
-10,000
| -11% | -$197K | 0.21% | 61 |
|
|
2022
Q2 | $1.54M | Buy |
+88,000
| New | +$1.54M | 0.24% | 62 |
|
|
2022
Q1 | – | Sell |
-298,700
| Closed | -$4.87M | – | 81 |
|
|
2021
Q4 | $4.87M | Buy |
+298,700
| New | +$4.87M | 0.49% | 37 |
|
|
2020
Q2 | – | Sell |
-16,240
| Closed | -$222K | – | 72 |
|
|
2020
Q1 | $222K | Buy |
+16,240
| New | +$222K | 0.26% | 43 |
|